Int. Journal of Clinical Pharmacology and Therapeutics, Volume 59 (2021) - April (298 - 307)

Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia

Sunghee Kuk1, Seoyoung Kim2, Euitae Kim2, Bo-Hyung Kim3, 4, 5, 6, Woojoo Lee7, Sang-In Park8
1 Department of Statistics, Inha University, Incheon, 2 Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, 3 Department of Clinical Pharmacology and Therapeutics, Seoul, 4 East-West Medical Research Institute, 5 Department of Clinical Pharmacology and Therapeutics, College of Medicine, 6 Department of Biomedical Science and Technology, Kyung Hee University, 7 Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, and 8 Department of Pharmacology, College of Medicine, Kangwon National University, Chuncheon, Republic of Korea

Add to Cart    

 

DOI 10.5414/CP203814

Abstract

Objective: Metabolic side effects of antipsychotics significantly affect adherence to medication. We aimed to identify factors associated with the occurrence of metabolic diseases among Korean patients with schizophrenia (SCZ) from the national health insurance system database. We evaluated the frequency of antidiabetic and antihyperlipidemic use after diagnosis of SCZ according to typical or atypical antipsychotic use.
Materials and methods: Among the 43,800 patients diagnosed with SCZ between 2008 and 2012, 29,591 patients who had no metabolic diseases before the diagnosis were included in the analysis to investigate the occurrence of metabolic diseases associated with antipsychotic use. The associations between the development of metabolic diseases and patient characteristics were evaluated using logistic regression analysis.
Results: Use of both typical and atypical antipsychotics (multivariate-adjusted odds ratio (OR), 1.2513; 95% confidence interval (CI), 1.0953 – 1.4294) was associated with higher incidence of metabolic diseases than without their use. Among the atypical antipsychotics, use of clozapine (multivariate-adjusted OR, 1.1959; 95% CI, 1.0086 – 1.4179) and quetiapine (multivariate-adjusted OR, 1.1284; 95% CI, 1.0446 – 1.2189) showed higher incidence of metabolic diseases compared to that without their use. Among the patients using ≥ 1 type of antidiabetic or antihyperlipidemic agents within 6 years after diagnosis of SCZ, the proportion of patients using only atypical antipsychotics was greater than those using only typical antipsychotics.
Conclusion: The use of both typical and atypical antipsychotics, and clozapine and quetiapine treatment, may be associated with the occurrence of metabolic diseases in patients with SCZ. Additional prospective studies with accurate dosage information are needed to validate our findings.

Author Details

Authors

Departments

  • 1 Department of Statistics, Inha University, Incheon,
  • 2 Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam,
  • 3 Department of Clinical Pharmacology and Therapeutics, Seoul,
  • 4 East-West Medical Research Institute,
  • 5 Department of Clinical Pharmacology and Therapeutics, College of Medicine,
  • 6 Department of Biomedical Science and Technology, Kyung Hee University,
  • 7 Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, and
  • 8 Department of Pharmacology, College of Medicine, Kangwon National University, Chuncheon, Republic of Korea

Address


Sang-In Park, MD, PhD
1 Gangwondaehakgil, Chuncheon-si,
Gangwon-do 24341, Republic of Korea
Email: [email protected]

Log in for Subscribers

Citation

Sunghee Kuk, Seoyoung Kim, Euitae Kim, Bo-Hyung Kim, Woojoo Lee, Sang-In Park. Occurrence of metabolic diseases associated with antipsychotic use among Korean patients with schizophrenia
. Int J Clin Pharmacol Ther. 2021; 59: 298-307. doi: 10.5414/CP203814. Pubmed: https://pubmed.ncbi.nlm.nih.gov/33250073/; PMID: 33250073.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart